Form D · Other Investment Fund

BioPharma Secured Investments III, S.ar.l

Luxembourg, N4 · CIK 0001580498

Offering snapshot reported Jul 17, 2013 · SEC filing

Reported sold: $248M
Investors reported: 16
Minimum accepted: $100K
First sale: Feb 25, 2013

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 17, 2013	Initial	$247,750,000	No comparison	16	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-199818

Source: Form D, filed Jul 17, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOPHARMA SECURED INVESTMENTS III SARL

Investment adviser: PHARMAKON ADVISORS, LP

Gross asset value: $345M
Beneficial owners: 76
ADV minimum commitment: $0

Reported in Form ADV on Jun 13, 2017. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator INTERTRUST LUXEMBOURG L-2453 LUXEMBOURG, Luxembourg Investor statements: Some (provided to some but not all investors) Related to adviser: No

Auditor ERNST & YOUNG LLP DUBLIN 2, Ireland

Custodian BANK OF AMERICA DALLAS, Texas, United States Related to adviser: No

Custodian THE ROYAL BANK OF SCOTLAND L-1012, Luxembourg Related to adviser: No

Marketer GROTON SECURITIES LLC NEW YORK, New York, United States Related to adviser: No

Marketer VIER KLEEBLATT INVESTMENT AG ZURICH, Switzerland Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

GROTON SECURITIES LLC
CRD 126600 · SEC 8-65896

Filing source

Form ADV 1113667 · Jun 13, 2017 · Schedule D 7.B.(1), fund 805-1253180070

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Fanny Auenallah	Executive
David Catala	Executive
Andrew O'shea	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

65 Boulevard Grande Duchesse Charlotte
Luxembourg, N4, L1331